# AI Slashes Protein Synthesis Costs by 40% in Autonomous Lab Breakthrough

OpenAI announced that its latest GPT-5 model has achieved a significant cost reduction in biotechnology manufacturing. Working in partnership with Ginkgo Bioworks, the AI system cut cell-free protein synthesis costs by 40%.

The breakthrough came from combining GPT-5's capabilities with Ginkgo's cloud-based laboratory automation in what researchers call "closed-loop experimentation." This approach allows the AI to design experiments, analyze results, and continuously refine its methods without human intervention at each step.

Cell-free protein synthesis is a crucial biotechnology process used to manufacture proteins for pharmaceuticals, industrial enzymes, and research applications. Unlike traditional methods that rely on living cells, cell-free systems offer faster production times and greater flexibility, but have historically been expensive.

The 40% cost reduction could make protein-based therapeutics